Claritev provides healthcare claims, pricing and data analytics services to health plans and other payers. CTEV reports earnings on Mon, Nov 9, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 21 | Barclays | Target raised | Buy | |
| Aug 10 | Citigroup | Maintained | Buy | |
| Aug 10 | Canaccord Genuity | Target raised | Buy | |
| Jul 21 | Canaccord Genuity | Target raised | Buy | |
| May 29 | Canaccord Genuity | Initiated | Buy |
Whale Options Flow
90DNo whale options trades in CTEV in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CTEV is in one of them and how their past CTEV trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered CTEV in an article yet. Here's the latest on the wider market.
About Claritev
Claritev is a healthcare technology and data company based in McLean, Virginia. Its software and analytics help health insurers and other payers review claims before payment, control costs for care from providers outside their networks, manage provider networks and find billing errors. Its direct customers are mainly payers, including administrative services platforms and third party administrators, which offer its solutions to employers, plan sponsors and their members. The services run on a shared platform that connects to clients' systems.
- Headquarters
- Mclean, VA